Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


J Am Soc Nephrol 15: 3026-3034, 2004
© 2004 American Society of Nephrology
doi: 10.1097/01.ASN.0000146425.58046.6A

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seibold, S.
Right arrow Articles by Galle, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seibold, S.
Right arrow Articles by Galle, J.

BASIC SCIENCE

Oxidized LDL Induces Proliferation and Hypertrophy in Human Umbilical Vein Endothelial Cells via Regulation of p27Kip1 Expression: Role of RhoA

Stefan Seibold*, Dorothea Schürle*, Alexandra Heinloth*, Gunter Wolf{dagger}, Martin Wagner* and Jan Galle*

*Department of Medicine, Division of Nephrology, University Hospital, Würzburg, Germany; and {dagger}Department of Medicine, Division of Nephrology, University Hospital, Hamburg, Germany

Correspondence to Prof. Dr. Jan Galle, Department of Medicine, University Hospital Würzburg, Joseph-Schneider-Strasse 2, D-97080 Würzburg, Germany. Phone: +49-931-201-36194; Fax: +49-931-201-36502; E-mail: J-C.Galle{at}mail.uni-wuerzburg.de

Oxidized LDL (OxLDL) induces proliferation in human umbilical vein endothelial cells (HUVEC). The influence of OxLDL on the cyclin-dependent kinase inhibitor p27Kip1, on the activity of the small GTPase RhoA as a known regulator of p27Kip1, and on resulting cell proliferation and hypertrophy was studied. HUVEC were stimulated with OxLDL (1 to 50 µg/ml). Proliferation was quantified by 3H-thymidine incorporation, colorimetric 3-(4,5-dimethyl-2-thiazyl)-2,5-diphenyl-2h-tetrazolium bromide assay, and cell count and was compared with proliferation of HUVEC that were transfected with dominant negative RhoA or treated with the Rho-kinase inhibitor Y27632. Hypertrophy was quantified by 3H-leucine incorporation and by planimetry. p27Kip1 expression was determined by Western blot analysis. p27Kip1 was downregulated by transient transfection with antisense oligonucleotides. Low concentrations of OxLDL induced proliferation of HUVEC, paralleled by a persistent decrease of p27Kip1 expression. With the use of antisense oligonucleotides, further downregulation of p27Kip1 expression enhanced the OxLDL-induced proliferative response. High concentrations of OxLDL resulted in cellular hypertrophy and caused a delayed increase in p27Kip1 expression after initial downregulation. Concomitant, OxLDL caused a significant activation of the small GTPase RhoA. In cells that were transfected with dominant negative RhoA, the effect of OxLDL on p27Kip1 expression and on cellular proliferation was abolished. HUVEC that were preincubated with the Rho-kinase inhibitor Y27632 also showed a significantly decreased proliferative response to OxLDL stimulation. In summary, OxLDL has a dual effect on cell-cycle progression via regulation of p27Kip1 expression, resulting in cellular proliferation and hypertrophy, involving activation of RhoA. OxLDL may importantly contribute to vascular hyperplasia in atherosclerosis and other diseases associated with increased levels of OxLDL.




This article has been cited by other articles:


Home page
FASEB J.Home page
H.-W. Wang, P.-Y. Liu, N. Oyama, Y. Rikitake, S. Kitamoto, J. Gitlin, J. K. Liao, and W. A. Boisvert
Deficiency of ROCK1 in bone marrow-derived cells protects against atherosclerosis in LDLR-/- mice
FASEB J, October 1, 2008; 22(10): 3561 - 3570.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
G. B. Kowalsky, F. J. Byfield, and I. Levitan
oxLDL facilitates flow-induced realignment of aortic endothelial cells
Am J Physiol Cell Physiol, August 1, 2008; 295(2): C332 - C340.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
P. Hamel, E. Abed, L. Brissette, and R. Moreau
Characterization of oxidized low-density lipoprotein-induced hormesis-like effects in osteoblastic cells
Am J Physiol Cell Physiol, April 1, 2008; 294(4): C1021 - C1033.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. R. Croft and M. F. Olson
The Rho GTPase Effector ROCK Regulates Cyclin A, Cyclin D1, and p27Kip1 Levels by Distinct Mechanisms
Mol. Cell. Biol., June 15, 2006; 26(12): 4612 - 4627.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
F. J. Byfield, S. Tikku, G. H. Rothblat, K. J. Gooch, and I. Levitan
OxLDL increases endothelial stiffness, force generation, and network formation
J. Lipid Res., April 1, 2006; 47(4): 715 - 723.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP